A detailed history of Family Wealth Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Family Wealth Group, LLC holds 2,505 shares of ABBV stock, worth $439,827. This represents 0.53% of its overall portfolio holdings.

Number of Shares
2,505
Previous 2,566 2.38%
Holding current value
$439,827
Previous $440,000 12.27%
% of portfolio
0.53%
Previous 0.48%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $9,994 - $12,159
-61 Reduced 2.38%
2,505 $494,000
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $2,167 - $2,530
-14 Reduced 0.54%
2,566 $440,000
Q1 2024

Aug 14, 2024

BUY
$159.82 - $182.1 $8,630 - $9,833
54 Added 2.14%
2,580 $469,000
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $347,577 - $391,454
2,526 New
2,526 $391,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Family Wealth Group, LLC Portfolio

Follow Family Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Family Wealth Group, LLC with notifications on news.